Mono Pharmacare Ltd
Incorporated in 1994, Mono Pharmacare Ltd is in the business of distribution of Pharmaceutical items[1]
- Market Cap ₹ 18.6 Cr.
- Current Price ₹ 10.5
- High / Low ₹ 27.5 / 9.45
- Stock P/E 53.0
- Book Value ₹ 17.9
- Dividend Yield 0.00 %
- ROCE 3.46 %
- ROE 1.12 %
- Face Value ₹ 10.0
Pros
- Stock is trading at 0.59 times its book value
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has low interest coverage ratio.
- Company has a low return on equity of 7.19% over last 3 years.
- Company might be capitalizing the interest cost
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals
Part of Nifty SME Emerge
Half Yearly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| 13.92 | 70.72 | 82.64 | 92.91 | |
| 13.05 | 68.27 | 80.08 | 90.87 | |
| Operating Profit | 0.87 | 2.45 | 2.56 | 2.04 |
| OPM % | 6.25% | 3.46% | 3.10% | 2.20% |
| 0.20 | 1.70 | 2.54 | 0.00 | |
| Interest | 0.38 | 1.21 | 1.24 | 1.54 |
| Depreciation | 0.02 | 0.08 | 0.08 | 0.08 |
| Profit before tax | 0.67 | 2.86 | 3.78 | 0.42 |
| Tax % | 19.40% | 14.69% | 18.25% | 19.05% |
| 0.54 | 2.44 | 3.09 | 0.35 | |
| EPS in Rs | 0.44 | 1.38 | 1.75 | 0.20 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 88% |
| TTM: | 12% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -13% |
| TTM: | -89% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | -54% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 7% |
| Last Year: | 1% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Equity Capital | 12.37 | 17.67 | 17.67 | 17.67 |
| Reserves | 1.03 | 10.44 | 13.53 | 13.88 |
| 12.51 | 13.27 | 23.69 | 26.70 | |
| 3.15 | 4.02 | 11.18 | 19.36 | |
| Total Liabilities | 29.06 | 45.40 | 66.07 | 77.61 |
| 0.19 | 0.14 | 0.22 | 0.15 | |
| CWIP | 0.00 | 0.00 | 0.02 | 0.02 |
| Investments | 1.97 | 3.59 | 10.84 | 0.00 |
| 26.90 | 41.67 | 54.99 | 77.44 | |
| Total Assets | 29.06 | 45.40 | 66.07 | 77.61 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| -13.49 | -10.32 | -0.73 | ||
| -2.18 | -1.66 | -7.43 | ||
| 15.90 | 12.00 | 8.02 | ||
| Net Cash Flow | 0.23 | 0.02 | -0.14 | |
| Free Cash Flow | -13.70 | -10.35 | -0.91 | |
| CFO/OP | -1,530% | -406% | -0% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Debtor Days | 211.87 | 90.01 | 83.48 | 0.00 |
| Inventory Days | 466.39 | 118.95 | 136.54 | 105.42 |
| Days Payable | 64.21 | 16.55 | 45.79 | 69.00 |
| Cash Conversion Cycle | 614.04 | 192.41 | 174.22 | 36.42 |
| Working Capital Days | 377.06 | 146.94 | 148.36 | -20.07 |
| ROCE % | 12.10% | 10.43% | 3.46% |
Insights
In beta| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| Domestic revenue share (consolidated) % |
|
||
| Number of associates and joint ventures count |
|||
| Number of permanent employees employees |
|||
Extracted by Screener AI
Documents
Announcements
-
General Updates
16 July 2026 - Surana and Kothari Associates LLP consents to act as Secretarial Auditor and Scrutinizer for FY 2026-27.
-
Change in Auditors
16 July 2026 - BG Kalal & Co. consented to act as Internal Auditor for FY 2026-27.
-
Resignation of Director/KMP/SMP
16 July 2026 - Mono Pharmacare Limited has informed about Resignation of Director/KMP/SMP
-
Outcome of Board Meeting
16 July 2026 - Board approved FY26 audited standalone and consolidated results; noted company secretary resignation and auditor appointments on 16 July 2026.
-
Resignation
16 July 2026 - Mono Pharmacare Limited has informed regarding Resignation of Mr Rahul Joshi as Company Secretary & Compliance Officer of the company w.e.f. July 01, 2026.
Business Overview:[1]
MPL is a distributor and supplier of a wide array of pharmaceutical products and medicines. It offers
Health Care Products, Antibiotic medicines, Cough Cold Anti-Allergic medicines, Antifungal medicines, Nutraceutical medicines, Analgesic & Antipyretic medicines, Antacid
& Antiemetic medicines, Cardiac – Diabetic medicines, and Cosmo care products.